Patent | Date |
---|
Cancer Vaccine Formulation App 20220160849 - SHIKU; Hiroshi ;   et al. | 2022-05-26 |
Complex App 20220111061 - HARADA; Naozumi ;   et al. | 2022-04-14 |
Long Chain Antigen Containing Interepitope Sequence That Promotes Antigen Presentation To T Cells App 20220062398 - SHIKU; Hiroshi ;   et al. | 2022-03-03 |
Long chain antigen containing interepitope sequence that promotes antigen presentation to T cells Grant 11,179,450 - Shiku , et al. November 23, 2 | 2021-11-23 |
Mucosal Vaccine Composition For Bovine Mastitis App 20210322531 - HAYASHI; Tomohito ;   et al. | 2021-10-21 |
Therapeutic agent associated with suppression of proliferation and metastasis of tumor, which comprises exosomes released from cytotoxic T cells and targets cancer stromal/mesenchymal cells Grant 11,083,744 - Shiku , et al. August 10, 2 | 2021-08-10 |
Exosome Production Method App 20210239664 - Shiku; Hiroshi ;   et al. | 2021-08-05 |
Pretreatment Drug For T Cell Infusion Therapy For Immune-checkpoint Inhibitor-resistant Tumor App 20190111078 - SHIKU; Hiroshi ;   et al. | 2019-04-18 |
T Cell Inducing Vaccine Containing An Interepitope Sequence That Promotes Antigen Presentation App 20190015490 - SHIKU; Hiroshi ;   et al. | 2019-01-17 |
Therapeutic Agent Associated With Suppression Of Proliferation And Metastasis Of Tumor, Which Comprises Exosomes Released From Cytotoxic T Cells And Targets Cancer Stromal/mesenchymal Cells App 20180177816 - SHIKU; Hiroshi ;   et al. | 2018-06-28 |
Nasal vaccine for Streptococcus pneumoniae Grant 9,833,407 - Yuki , et al. December 5, 2 | 2017-12-05 |
Nasal Vaccine For Streptococcus Pneumoniae App 20170014338 - YUKI; Yoshikazu ;   et al. | 2017-01-19 |
T Cell Inducing Vaccine Containing An Interepitope Sequence That Promotes Antigen Presentation App 20160367651 - SHIKU; Hiroshi ;   et al. | 2016-12-22 |
Liposome and method for injecting substance to cell using this liposome Grant 9,023,384 - Morita , et al. May 5, 2 | 2015-05-05 |
Hybrid gel comprising chemically crosslinked hyaluronic acid derivative and pharmaceutical composition comprising the same Grant 8,987,230 - Akiyoshi , et al. March 24, 2 | 2015-03-24 |
Mucosal vaccine using cationic nanogel Grant 8,961,983 - Akiyoshi , et al. February 24, 2 | 2015-02-24 |
Mucosal Vaccine Using Cationic Nanogel App 20140370056 - Akiyoshi; Kazunari ;   et al. | 2014-12-18 |
Vaccine Preparation For Cancer Treatment App 20140322344 - Shiku; Hiroshi ;   et al. | 2014-10-30 |
Hyaluronic acid derivative and pharmaceutical composition thereof Grant 8,759,322 - Akiyoshi , et al. June 24, 2 | 2014-06-24 |
Hyaluronic Acid Derivative And Pharmaceutical Composition Thereof App 20110212901 - Akiyoshi; Kazunari ;   et al. | 2011-09-01 |
Mucosal Vaccine Using Cationic Nanogel App 20110206729 - Akiyoshi; Kazunari ;   et al. | 2011-08-25 |
Osteogenic Biomaterial Containing Osteogenesis Promoting Substance And Nanogel App 20100221345 - Akiyoshi; Kazunari ;   et al. | 2010-09-02 |
Hybrid Gel Comprising Chemically Crosslinked Hyaluronic Acid Derivative And Pharmaceutical Composition Comprising The Same App 20100204102 - Akiyoshi; Kazunari ;   et al. | 2010-08-12 |
Liposome And Method For Injecting Substance To Cell Using This Liposome App 20080279918 - Morita; Ikuo ;   et al. | 2008-11-13 |
Composition Comprising Platelet-Rich Plasma App 20070253940 - Sumida; Emi ;   et al. | 2007-11-01 |
Method for preparing platelet-rich plasma App 20050170327 - Sumida, Emi ;   et al. | 2005-08-04 |
High purity polysaccharide containing a hydrophobic group and process for producing it Grant 6,566,516 - Sunamoto , et al. May 20, 2 | 2003-05-20 |
High purity polysaccharide containing hydrophobic group and process for producing it App 20020143160 - Sunamoto, Junzo ;   et al. | 2002-10-03 |